Structure

Physi-Chem Properties

Molecular Weight:  582.26
Volume:  615.687
LogP:  7.89
LogD:  4.471
LogS:  -3.104
# Rotatable Bonds:  12
TPSA:  127.45
# H-Bond Aceptor:  7
# H-Bond Donor:  5
# Rings:  5
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.085
Synthetic Accessibility Score:  3.633
Fsp3:  0.306
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.411
MDCK Permeability:  1.7107280655181967e-05
Pgp-inhibitor:  0.192
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.019
20% Bioavailability (F20%):  1.0
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.007
Plasma Protein Binding (PPB):  101.56365203857422%
Volume Distribution (VD):  0.487
Pgp-substrate:  0.5127279758453369%

ADMET: Metabolism

CYP1A2-inhibitor:  0.199
CYP1A2-substrate:  0.549
CYP2C19-inhibitor:  0.949
CYP2C19-substrate:  0.063
CYP2C9-inhibitor:  0.884
CYP2C9-substrate:  0.997
CYP2D6-inhibitor:  0.745
CYP2D6-substrate:  0.874
CYP3A4-inhibitor:  0.39
CYP3A4-substrate:  0.313

ADMET: Excretion

Clearance (CL):  5.973
Half-life (T1/2):  0.398

ADMET: Toxicity

hERG Blockers:  0.146
Human Hepatotoxicity (H-HT):  0.058
Drug-inuced Liver Injury (DILI):  0.935
AMES Toxicity:  0.542
Rat Oral Acute Toxicity:  0.964
Maximum Recommended Daily Dose:  0.99
Skin Sensitization:  0.955
Carcinogencity:  0.095
Eye Corrosion:  0.003
Eye Irritation:  0.894
Respiratory Toxicity:  0.437

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC121568

Natural Product ID:  NPC121568
Common Name*:   (+)-Myristinin D
IUPAC Name:   9-phenyl-1-[2,4,6-trihydroxy-3-[(2S,4R)-7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl]phenyl]nonan-1-one
Synonyms:   (+)-Myristinin D
Standard InCHIKey:  NWJOIWGNEIDTTG-NSJVFKKDSA-N
Standard InCHI:  InChI=1S/C36H38O7/c37-25-16-14-24(15-17-25)32-21-28(27-19-18-26(38)20-33(27)43-32)34-30(40)22-31(41)35(36(34)42)29(39)13-9-4-2-1-3-6-10-23-11-7-5-8-12-23/h5,7-8,11-12,14-20,22,28,32,37-38,40-42H,1-4,6,9-10,13,21H2/t28-,32+/m1/s1
SMILES:  Oc1ccc2c(c1)O[C@@H](C[C@H]2c1c(O)cc(c(c1O)C(=O)CCCCCCCCc1ccccc1)O)c1ccc(cc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL448072
PubChem CID:   497362
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0002991] Hydroxyflavonoids
          • [CHEMONTID:0002993] 7-hydroxyflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6742 Knema elegans Species Myristicaceae Eukaryota n.a. n.a. n.a. PMID[16309311]
NPO6742 Knema elegans Species Myristicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2216 Individual Protein DNA polymerase beta Rattus norvegicus IC50 = 4300.0 nM PMID[553308]
NPT2216 Individual Protein DNA polymerase beta Rattus norvegicus IC50 = 1200.0 nM PMID[553308]
NPT2216 Individual Protein DNA polymerase beta Rattus norvegicus Ki = 12000.0 nM PMID[553308]
NPT2216 Individual Protein DNA polymerase beta Rattus norvegicus Kis = 23.0 uM PMID[553308]
NPT2216 Individual Protein DNA polymerase beta Rattus norvegicus Kii = 0.8 uM PMID[553308]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 30.0 % PMID[553308]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC121568 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9799 High Similarity NPC1796
0.9799 High Similarity NPC257166
0.9733 High Similarity NPC15815
0.9733 High Similarity NPC51247
0.9728 High Similarity NPC178484
0.9669 High Similarity NPC226462
0.9669 High Similarity NPC98023
0.9669 High Similarity NPC195136
0.9669 High Similarity NPC42965
0.9667 High Similarity NPC322459
0.9667 High Similarity NPC318527
0.9667 High Similarity NPC324358
0.9667 High Similarity NPC323627
0.9664 High Similarity NPC79375
0.9664 High Similarity NPC37253
0.9662 High Similarity NPC39154
0.9662 High Similarity NPC208011
0.9662 High Similarity NPC78324
0.9662 High Similarity NPC115601
0.9658 High Similarity NPC122894
0.9603 High Similarity NPC105584
0.96 High Similarity NPC32867
0.96 High Similarity NPC69531
0.9592 High Similarity NPC3642
0.9592 High Similarity NPC132345
0.9542 High Similarity NPC473012
0.9539 High Similarity NPC121647
0.9536 High Similarity NPC475184
0.9536 High Similarity NPC208258
0.9533 High Similarity NPC134171
0.9533 High Similarity NPC66441
0.9533 High Similarity NPC300668
0.9533 High Similarity NPC182555
0.953 High Similarity NPC174086
0.9481 High Similarity NPC473009
0.9477 High Similarity NPC312273
0.9477 High Similarity NPC301256
0.9474 High Similarity NPC295090
0.9463 High Similarity NPC476551
0.9463 High Similarity NPC78835
0.9463 High Similarity NPC317715
0.9463 High Similarity NPC476553
0.9463 High Similarity NPC309512
0.9463 High Similarity NPC148945
0.9463 High Similarity NPC316960
0.9463 High Similarity NPC204561
0.9463 High Similarity NPC476552
0.9456 High Similarity NPC261271
0.9456 High Similarity NPC475348
0.9452 High Similarity NPC470135
0.9452 High Similarity NPC470136
0.9452 High Similarity NPC39045
0.9419 High Similarity NPC473010
0.9408 High Similarity NPC287789
0.9408 High Similarity NPC271741
0.9404 High Similarity NPC201227
0.9404 High Similarity NPC258474
0.94 High Similarity NPC43345
0.9392 High Similarity NPC152233
0.9388 High Similarity NPC470132
0.9388 High Similarity NPC470134
0.9388 High Similarity NPC470131
0.9388 High Similarity NPC470133
0.9388 High Similarity NPC109183
0.9388 High Similarity NPC473078
0.9359 High Similarity NPC251336
0.9346 High Similarity NPC195167
0.9346 High Similarity NPC51760
0.9342 High Similarity NPC56049
0.9342 High Similarity NPC309648
0.9342 High Similarity NPC61112
0.9342 High Similarity NPC198489
0.9342 High Similarity NPC54830
0.9338 High Similarity NPC324447
0.9329 High Similarity NPC473016
0.932 High Similarity NPC271288
0.932 High Similarity NPC473014
0.932 High Similarity NPC235217
0.929 High Similarity NPC473011
0.9286 High Similarity NPC184326
0.9286 High Similarity NPC292863
0.9276 High Similarity NPC121649
0.9276 High Similarity NPC205026
0.9276 High Similarity NPC248739
0.9276 High Similarity NPC14606
0.9276 High Similarity NPC150908
0.9276 High Similarity NPC186227
0.9276 High Similarity NPC158027
0.9276 High Similarity NPC215203
0.9276 High Similarity NPC52611
0.9276 High Similarity NPC100049
0.9276 High Similarity NPC265624
0.9276 High Similarity NPC159707
0.9262 High Similarity NPC145467
0.9257 High Similarity NPC228779
0.9257 High Similarity NPC285630
0.9257 High Similarity NPC127059
0.9252 High Similarity NPC107177
0.9252 High Similarity NPC223812
0.9252 High Similarity NPC85162
0.9252 High Similarity NPC185276
0.9252 High Similarity NPC81697
0.9252 High Similarity NPC77794
0.9252 High Similarity NPC278249
0.9252 High Similarity NPC125894
0.9231 High Similarity NPC63438
0.9226 High Similarity NPC137232
0.9226 High Similarity NPC114652
0.9226 High Similarity NPC18380
0.9226 High Similarity NPC175513
0.9221 High Similarity NPC123544
0.9211 High Similarity NPC72425
0.9211 High Similarity NPC303485
0.9211 High Similarity NPC194593
0.9211 High Similarity NPC71061
0.9211 High Similarity NPC290830
0.9205 High Similarity NPC111112
0.9205 High Similarity NPC138299
0.9205 High Similarity NPC222713
0.9205 High Similarity NPC67322
0.92 High Similarity NPC288840
0.92 High Similarity NPC291746
0.9195 High Similarity NPC283234
0.9195 High Similarity NPC296998
0.9195 High Similarity NPC10990
0.9195 High Similarity NPC473077
0.9195 High Similarity NPC300988
0.9195 High Similarity NPC308200
0.9189 High Similarity NPC236766
0.9189 High Similarity NPC194949
0.9189 High Similarity NPC473015
0.9189 High Similarity NPC131568
0.9189 High Similarity NPC131579
0.9189 High Similarity NPC282957
0.9189 High Similarity NPC473013
0.9189 High Similarity NPC471473
0.9189 High Similarity NPC471524
0.9189 High Similarity NPC471523
0.9189 High Similarity NPC197252
0.9184 High Similarity NPC32739
0.9184 High Similarity NPC265040
0.9184 High Similarity NPC227579
0.9184 High Similarity NPC223500
0.9184 High Similarity NPC328164
0.9184 High Similarity NPC78
0.9184 High Similarity NPC10937
0.9184 High Similarity NPC220998
0.9184 High Similarity NPC166482
0.9184 High Similarity NPC66515
0.9184 High Similarity NPC296917
0.9184 High Similarity NPC324436
0.9184 High Similarity NPC306829
0.9184 High Similarity NPC324134
0.9184 High Similarity NPC40833
0.9184 High Similarity NPC228504
0.9184 High Similarity NPC76372
0.9184 High Similarity NPC125855
0.9184 High Similarity NPC182852
0.9184 High Similarity NPC161506
0.9184 High Similarity NPC107572
0.9184 High Similarity NPC37496
0.9184 High Similarity NPC166934
0.9184 High Similarity NPC194432
0.9184 High Similarity NPC148757
0.9184 High Similarity NPC76338
0.9184 High Similarity NPC177354
0.9184 High Similarity NPC1089
0.9184 High Similarity NPC167624
0.9184 High Similarity NPC64915
0.9161 High Similarity NPC114147
0.9139 High Similarity NPC29777
0.9139 High Similarity NPC471115
0.9133 High Similarity NPC132592
0.9133 High Similarity NPC35150
0.9133 High Similarity NPC161191
0.9133 High Similarity NPC39195
0.9133 High Similarity NPC160821
0.9133 High Similarity NPC106328
0.9128 High Similarity NPC301276
0.9128 High Similarity NPC214774
0.9128 High Similarity NPC20488
0.9128 High Similarity NPC312973
0.9128 High Similarity NPC83357
0.9128 High Similarity NPC475052
0.9128 High Similarity NPC267375
0.9128 High Similarity NPC54577
0.9128 High Similarity NPC246948
0.9128 High Similarity NPC142405
0.9128 High Similarity NPC470647
0.9128 High Similarity NPC476088
0.9128 High Similarity NPC195621
0.9128 High Similarity NPC67805
0.9128 High Similarity NPC176229
0.9128 High Similarity NPC472629
0.9128 High Similarity NPC477955
0.9128 High Similarity NPC88964
0.9128 High Similarity NPC474161
0.9128 High Similarity NPC111786
0.9125 High Similarity NPC477529
0.9122 High Similarity NPC68104

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC121568 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9533 High Similarity NPD8443 Clinical (unspecified phase)
0.9051 High Similarity NPD7852 Clinical (unspecified phase)
0.8981 High Similarity NPD6959 Discontinued
0.8973 High Similarity NPD1552 Clinical (unspecified phase)
0.8973 High Similarity NPD1550 Clinical (unspecified phase)
0.8968 High Similarity NPD7768 Phase 2
0.8912 High Similarity NPD1549 Phase 2
0.8831 High Similarity NPD7411 Suspended
0.8808 High Similarity NPD7410 Clinical (unspecified phase)
0.8808 High Similarity NPD4378 Clinical (unspecified phase)
0.8766 High Similarity NPD4380 Phase 2
0.8718 High Similarity NPD2393 Clinical (unspecified phase)
0.8718 High Similarity NPD7819 Suspended
0.8671 High Similarity NPD7075 Discontinued
0.8599 High Similarity NPD7096 Clinical (unspecified phase)
0.8581 High Similarity NPD1510 Phase 2
0.8537 High Similarity NPD7804 Clinical (unspecified phase)
0.8523 High Similarity NPD2796 Approved
0.8466 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8466 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8466 Intermediate Similarity NPD6166 Phase 2
0.8438 Intermediate Similarity NPD3749 Approved
0.8438 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8418 Intermediate Similarity NPD1934 Approved
0.8311 Intermediate Similarity NPD1240 Approved
0.8299 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8235 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8221 Intermediate Similarity NPD5494 Approved
0.82 Intermediate Similarity NPD1607 Approved
0.8187 Intermediate Similarity NPD6801 Discontinued
0.8182 Intermediate Similarity NPD3750 Approved
0.8163 Intermediate Similarity NPD4908 Phase 1
0.8155 Intermediate Similarity NPD7074 Phase 3
0.8148 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8141 Intermediate Similarity NPD1511 Approved
0.8107 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD7054 Approved
0.8084 Intermediate Similarity NPD7473 Discontinued
0.807 Intermediate Similarity NPD8312 Approved
0.807 Intermediate Similarity NPD8313 Approved
0.8047 Intermediate Similarity NPD7472 Approved
0.8038 Intermediate Similarity NPD1512 Approved
0.8025 Intermediate Similarity NPD7390 Discontinued
0.8025 Intermediate Similarity NPD2801 Approved
0.8025 Intermediate Similarity NPD6799 Approved
0.8012 Intermediate Similarity NPD7808 Phase 3
0.8 Intermediate Similarity NPD2800 Approved
0.7988 Intermediate Similarity NPD5844 Phase 1
0.7961 Intermediate Similarity NPD6651 Approved
0.7953 Intermediate Similarity NPD7251 Discontinued
0.795 Intermediate Similarity NPD6599 Discontinued
0.7935 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD3882 Suspended
0.7922 Intermediate Similarity NPD1551 Phase 2
0.7914 Intermediate Similarity NPD8455 Phase 2
0.7907 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7904 Intermediate Similarity NPD6232 Discontinued
0.7895 Intermediate Similarity NPD6797 Phase 2
0.7875 Intermediate Similarity NPD5403 Approved
0.7862 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD3748 Approved
0.7857 Intermediate Similarity NPD2799 Discontinued
0.7849 Intermediate Similarity NPD6559 Discontinued
0.7824 Intermediate Similarity NPD3818 Discontinued
0.7808 Intermediate Similarity NPD1610 Phase 2
0.7806 Intermediate Similarity NPD6100 Approved
0.7806 Intermediate Similarity NPD6099 Approved
0.7778 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7458 Discontinued
0.7765 Intermediate Similarity NPD4360 Phase 2
0.7765 Intermediate Similarity NPD4363 Phase 3
0.7758 Intermediate Similarity NPD3817 Phase 2
0.7756 Intermediate Similarity NPD2344 Approved
0.7753 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD5401 Approved
0.775 Intermediate Similarity NPD2534 Approved
0.775 Intermediate Similarity NPD2532 Approved
0.775 Intermediate Similarity NPD2533 Approved
0.7736 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7701 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD2935 Discontinued
0.7688 Intermediate Similarity NPD5953 Discontinued
0.7687 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.768 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD7286 Phase 2
0.7658 Intermediate Similarity NPD1243 Approved
0.7654 Intermediate Similarity NPD920 Approved
0.7651 Intermediate Similarity NPD5402 Approved
0.764 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD7003 Approved
0.761 Intermediate Similarity NPD4628 Phase 3
0.7582 Intermediate Similarity NPD2313 Discontinued
0.758 Intermediate Similarity NPD5406 Approved
0.758 Intermediate Similarity NPD5408 Approved
0.758 Intermediate Similarity NPD5405 Approved
0.758 Intermediate Similarity NPD5404 Approved
0.7576 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD2309 Approved
0.7561 Intermediate Similarity NPD3226 Approved
0.7548 Intermediate Similarity NPD5124 Phase 1
0.7548 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7229 Phase 3
0.7485 Intermediate Similarity NPD3787 Discontinued
0.7483 Intermediate Similarity NPD1203 Approved
0.7468 Intermediate Similarity NPD3268 Approved
0.7451 Intermediate Similarity NPD6832 Phase 2
0.7444 Intermediate Similarity NPD4287 Approved
0.7434 Intermediate Similarity NPD2798 Approved
0.7432 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD4361 Phase 2
0.7421 Intermediate Similarity NPD8151 Discontinued
0.7421 Intermediate Similarity NPD2346 Discontinued
0.7415 Intermediate Similarity NPD1548 Phase 1
0.7414 Intermediate Similarity NPD3751 Discontinued
0.7405 Intermediate Similarity NPD7033 Discontinued
0.7394 Intermediate Similarity NPD7870 Phase 2
0.7394 Intermediate Similarity NPD7871 Phase 2
0.7381 Intermediate Similarity NPD1465 Phase 2
0.7372 Intermediate Similarity NPD943 Approved
0.7368 Intermediate Similarity NPD2797 Approved
0.7341 Intermediate Similarity NPD3926 Phase 2
0.734 Intermediate Similarity NPD7697 Approved
0.734 Intermediate Similarity NPD7696 Phase 3
0.734 Intermediate Similarity NPD7698 Approved
0.7333 Intermediate Similarity NPD8150 Discontinued
0.7321 Intermediate Similarity NPD7577 Discontinued
0.7317 Intermediate Similarity NPD7447 Phase 1
0.7314 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7314 Intermediate Similarity NPD7177 Discontinued
0.731 Intermediate Similarity NPD919 Approved
0.729 Intermediate Similarity NPD4625 Phase 3
0.7283 Intermediate Similarity NPD5710 Approved
0.7283 Intermediate Similarity NPD5711 Approved
0.7273 Intermediate Similarity NPD6778 Approved
0.7273 Intermediate Similarity NPD6779 Approved
0.7273 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD6780 Approved
0.7273 Intermediate Similarity NPD6782 Approved
0.7273 Intermediate Similarity NPD6781 Approved
0.7273 Intermediate Similarity NPD6273 Approved
0.7273 Intermediate Similarity NPD6777 Approved
0.7273 Intermediate Similarity NPD6776 Approved
0.7273 Intermediate Similarity NPD2861 Phase 2
0.7261 Intermediate Similarity NPD1613 Approved
0.7261 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD7213 Phase 3
0.7256 Intermediate Similarity NPD7212 Phase 2
0.7254 Intermediate Similarity NPD7783 Phase 2
0.7254 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7249 Intermediate Similarity NPD7435 Discontinued
0.7244 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD3764 Approved
0.7244 Intermediate Similarity NPD6798 Discontinued
0.7235 Intermediate Similarity NPD4288 Approved
0.7229 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD7199 Phase 2
0.7225 Intermediate Similarity NPD1247 Approved
0.7225 Intermediate Similarity NPD7584 Approved
0.7219 Intermediate Similarity NPD1201 Approved
0.7215 Intermediate Similarity NPD6355 Discontinued
0.7212 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD3225 Approved
0.7188 Intermediate Similarity NPD7701 Phase 2
0.7182 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD5761 Phase 2
0.7176 Intermediate Similarity NPD5760 Phase 2
0.7171 Intermediate Similarity NPD1608 Approved
0.7171 Intermediate Similarity NPD9717 Approved
0.7165 Intermediate Similarity NPD7801 Approved
0.7143 Intermediate Similarity NPD8434 Phase 2
0.7143 Intermediate Similarity NPD3266 Approved
0.7143 Intermediate Similarity NPD3267 Approved
0.7143 Intermediate Similarity NPD1470 Approved
0.7143 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD1729 Discontinued
0.7126 Intermediate Similarity NPD7427 Discontinued
0.7125 Intermediate Similarity NPD7097 Phase 1
0.7124 Intermediate Similarity NPD4749 Approved
0.7119 Intermediate Similarity NPD7228 Approved
0.7118 Intermediate Similarity NPD6844 Discontinued
0.7117 Intermediate Similarity NPD2654 Approved
0.7115 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD7874 Approved
0.7105 Intermediate Similarity NPD422 Phase 1
0.7105 Intermediate Similarity NPD6823 Phase 2
0.7102 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD4308 Phase 3
0.7074 Intermediate Similarity NPD7699 Phase 2
0.7074 Intermediate Similarity NPD7700 Phase 2
0.7059 Intermediate Similarity NPD5890 Approved
0.7059 Intermediate Similarity NPD3972 Approved
0.7059 Intermediate Similarity NPD5889 Approved
0.7056 Intermediate Similarity NPD6104 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data